mbk partners

Asian equities: Reit time, Reit place

Changing interest rate expectations prompt a renewed surge in Reit offerings as investors wonder whether wider equity market momentum can last.
March 11, 2019

MBK Partners pursues Chinese pharmaceuticals firm

The private equity firm will acquire Singapore-listed Chinese drug maker, AsiaPharm, for $252 million. Shareholders respond by pushing the traded share price up to near offer level.
February 10, 2008